<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang SY</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>UK Biobank Resource</funding><funding>Common Fund of the Office of the Director of the National Institutes of Health</funding><funding>Medical Research Council</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><funding>National Cancer Institute</funding><funding>National Institute of Mental Health</funding><funding>National Institutes of Health</funding><funding>National Human Genome Research Institute</funding><funding>National Institute on Drug Abuse</funding><pagination>349-358</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7919448</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(3)</volume><pubmed_abstract>Mitochondrial DNA copy number (mtDNA-CN) is a proxy for mitochondrial function and is associated with aging-related diseases. However, it is unclear how mtDNA-CN measured in blood can reflect diseases that primarily manifest in other tissues. Using the Genotype-Tissue Expression Project, we interrogated relationships between mtDNA-CN measured in whole blood and gene expression from whole blood and 47 additional tissues in 419 individuals. mtDNA-CN was significantly associated with expression of 700 genes in whole blood, including nuclear genes required for mtDNA replication. Significant enrichment was observed for splicing and ubiquitin-mediated proteolysis pathways, as well as target genes for the mitochondrial transcription factor NRF1. In nonblood tissues, there were more significantly </pubmed_abstract><journal>Genome research</journal><pubmed_title>Blood-derived mitochondrial DNA copy number is associated with gene expression across multiple tissues and is predictive for incident neurodegenerative disease.</pubmed_title><pmcid>PMC7919448</pmcid><funding_grant_id>MC_PC_17228</funding_grant_id><funding_grant_id>17731</funding_grant_id><funding_grant_id>R01 HL131573</funding_grant_id><funding_grant_id>R01HL13573</funding_grant_id><funding_grant_id>MC_QA137853</funding_grant_id><funding_grant_id>R01 HL144569</funding_grant_id><funding_grant_id>R01HL144569</funding_grant_id><pubmed_authors>Longchamps RJ</pubmed_authors><pubmed_authors>Guallar E</pubmed_authors><pubmed_authors>Arking DE</pubmed_authors><pubmed_authors>Pillalamarri VK</pubmed_authors><pubmed_authors>O'Rourke B</pubmed_authors><pubmed_authors>Castellani CA</pubmed_authors><pubmed_authors>Yang SY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blood-derived mitochondrial DNA copy number is associated with gene expression across multiple tissues and is predictive for incident neurodegenerative disease.</name><description>Mitochondrial DNA copy number (mtDNA-CN) is a proxy for mitochondrial function and is associated with aging-related diseases. However, it is unclear how mtDNA-CN measured in blood can reflect diseases that primarily manifest in other tissues. Using the Genotype-Tissue Expression Project, we interrogated relationships between mtDNA-CN measured in whole blood and gene expression from whole blood and 47 additional tissues in 419 individuals. mtDNA-CN was significantly associated with expression of 700 genes in whole blood, including nuclear genes required for mtDNA replication. Significant enrichment was observed for splicing and ubiquitin-mediated proteolysis pathways, as well as target genes for the mitochondrial transcription factor NRF1. In nonblood tissues, there were more significantly </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2026-05-02T11:36:55.744Z</modification><creation>2022-02-11T10:06:14.578Z</creation></dates><accession>S-EPMC7919448</accession><cross_references><pubmed>33441415</pubmed><doi>10.1101/gr.269381.120</doi></cross_references></HashMap>